Skip to main content
Top
Published in: Osteoporosis International 4/2008

Open Access 01-04-2008 | Special Position Paper

FRAX™ and the assessment of fracture probability in men and women from the UK

Authors: J. A. Kanis, O. Johnell, A. Oden, H. Johansson, E. McCloskey

Published in: Osteoporosis International | Issue 4/2008

Login to get access

Abstract

Summary

A fracture risk assessment tool (FRAX™) is developed based on the use of clinical risk factors with or without bone mineral density tests applied to the UK.

Introduction

The aim of this study was to apply an assessment tool for the prediction of fracture in men and women with the use of clinical risk factors (CRFs) for fracture with and without the use of femoral neck bone mineral density (BMD). The clinical risk factors, identified from previous meta-analyses, comprised body mass index (BMI, as a continuous variable), a prior history of fracture, a parental history of hip fracture, use of oral glucocorticoids, rheumatoid arthritis and other secondary causes of osteoporosis, current smoking, and alcohol intake 3 or more units daily.

Methods

Four models were constructed to compute fracture probabilities based on the epidemiology of fracture in the UK. The models comprised the ten-year probability of hip fracture, with and without femoral neck BMD, and the ten-year probability of a major osteoporotic fracture, with and without BMD. For each model fracture and death hazards were computed as continuous functions.

Results

Each clinical risk factor contributed to fracture probability. In the absence of BMD, hip fracture probability in women with a fixed BMI (25 kg/m2) ranged from 0.2% at the age of 50 years for women without CRF’s to 22% at the age of 80 years with a parental history of hip fracture (approximately 100-fold range). In men, the probabilities were lower, as was the range (0.1 to 11% in the examples above). For a major osteoporotic fracture the probabilities ranged from 3.5% to 31% in women, and from 2.8% to 15% in men in the example above. The presence of one or more risk factors increased probabilities in an incremental manner. The differences in probabilities between men and women were comparable at any given T-score and age, except in the elderly where probabilities were higher in women than in men due to the higher mortality of the latter.

Conclusion

The models provide a framework which enhances the assessment of fracture risk in both men and women by the integration of clinical risk factors alone and/or in combination with BMD.
Appendix
Available only for authorised users
Literature
1.
go back to reference World Health Organization (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. WHO Technical Report Series 843. WHO, Geneva World Health Organization (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. WHO Technical Report Series 843. WHO, Geneva
2.
go back to reference Marshall D, Johnell O, Wedel JJ (1996) Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. Br Med J 312:1254–1259 Marshall D, Johnell O, Wedel JJ (1996) Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. Br Med J 312:1254–1259
3.
go back to reference Johnell O, Kanis JA, Oden A, Johansson H et al (2005) Predictive value of bone mineral density for hip and other fractures. J Bone Miner Res 20:1185–1194PubMedCrossRef Johnell O, Kanis JA, Oden A, Johansson H et al (2005) Predictive value of bone mineral density for hip and other fractures. J Bone Miner Res 20:1185–1194PubMedCrossRef
4.
go back to reference Kanis JA, Johnell O, Oden A, Jönsson B, De Laet C, Dawson A (2000) Risk of hip fracture according to World Health Organization criteria for osteopenia and osteoporosis. Bone 27:585–590PubMedCrossRef Kanis JA, Johnell O, Oden A, Jönsson B, De Laet C, Dawson A (2000) Risk of hip fracture according to World Health Organization criteria for osteopenia and osteoporosis. Bone 27:585–590PubMedCrossRef
5.
go back to reference Hui SL, Slemenda CW, Johnston CC (1988) Age and bone mass as predictors of fracture in a prospective study. J Clin Invest 81:1804–1809PubMedCrossRef Hui SL, Slemenda CW, Johnston CC (1988) Age and bone mass as predictors of fracture in a prospective study. J Clin Invest 81:1804–1809PubMedCrossRef
6.
go back to reference De Laet CEDH, van Hout BA, Burger H, Hofman A, Pols HAP (1997) Bone density and risk of hip fracture in men and women: cross sectional analysis. Br Med J 315:221–225 De Laet CEDH, van Hout BA, Burger H, Hofman A, Pols HAP (1997) Bone density and risk of hip fracture in men and women: cross sectional analysis. Br Med J 315:221–225
7.
go back to reference Kanis JA, Johnell O, Oden A, Jönsson B, Dawson A, Dere W (2000) Risk of hip fracture derived from relative risks: an analysis applied to the population of Sweden. Osteoporos Int 11:120–127PubMedCrossRef Kanis JA, Johnell O, Oden A, Jönsson B, Dawson A, Dere W (2000) Risk of hip fracture derived from relative risks: an analysis applied to the population of Sweden. Osteoporos Int 11:120–127PubMedCrossRef
8.
go back to reference De Laet C, Oden A, Johansson H, Johnell O, Jonsson B, Kanis JA (2005) The impact of the use of multiple risk indicators for fracture on case-finding strategies: a mathematical approach. Osteoporos Int 16:313–318PubMedCrossRef De Laet C, Oden A, Johansson H, Johnell O, Jonsson B, Kanis JA (2005) The impact of the use of multiple risk indicators for fracture on case-finding strategies: a mathematical approach. Osteoporos Int 16:313–318PubMedCrossRef
9.
go back to reference Kanis JA, Johnell O, Oden A, De Laet C, Jonsson B, Dawson A (2002) Ten-year risk of osteoporotic fracture and the effect of risk factors on screening strategies. Bone 30:251–258PubMedCrossRef Kanis JA, Johnell O, Oden A, De Laet C, Jonsson B, Dawson A (2002) Ten-year risk of osteoporotic fracture and the effect of risk factors on screening strategies. Bone 30:251–258PubMedCrossRef
10.
go back to reference Kanis JA, Johansson H, Oden A et al (2004) A family history of fracture and fracture risk. Bone 35:1029–1037PubMedCrossRef Kanis JA, Johansson H, Oden A et al (2004) A family history of fracture and fracture risk. Bone 35:1029–1037PubMedCrossRef
11.
go back to reference Kanis JA, Johansson H, Oden A et al (2004) A meta-analysis of prior corticosteroid use and fracture risk. J Bone Miner Res 19:893–899PubMedCrossRef Kanis JA, Johansson H, Oden A et al (2004) A meta-analysis of prior corticosteroid use and fracture risk. J Bone Miner Res 19:893–899PubMedCrossRef
12.
go back to reference Kanis JA, Johnell O, De Laet C et al (2004) A meta-analysis of previous fracture and subsequent fracture risk. Bone 35:375–382PubMedCrossRef Kanis JA, Johnell O, De Laet C et al (2004) A meta-analysis of previous fracture and subsequent fracture risk. Bone 35:375–382PubMedCrossRef
13.
go back to reference De Laet C, Kanis JA, Oden A et al (2005) Body mass index as a prediction of fracture risk. A meta-analysis. Osteoporos Int 16:1330–1338PubMedCrossRef De Laet C, Kanis JA, Oden A et al (2005) Body mass index as a prediction of fracture risk. A meta-analysis. Osteoporos Int 16:1330–1338PubMedCrossRef
14.
go back to reference Kanis JA, Johansson H, Johnell O et al (2005) Alcohol intake as a risk factor for fracture. Osteoporos Int 16:737–742PubMedCrossRef Kanis JA, Johansson H, Johnell O et al (2005) Alcohol intake as a risk factor for fracture. Osteoporos Int 16:737–742PubMedCrossRef
15.
go back to reference Kanis JA, Johansson H, Oden A et al (2005) A meta-analysis of milk intake and fracture risk: low utility for case finding. Osteoporos Int 16:799–804PubMedCrossRef Kanis JA, Johansson H, Oden A et al (2005) A meta-analysis of milk intake and fracture risk: low utility for case finding. Osteoporos Int 16:799–804PubMedCrossRef
16.
go back to reference Kanis JA, Johnell O, Oden A et al (2005) Smoking and fracture risk: a meta-analysis. Osteoporos Int 16:222–228PubMedCrossRef Kanis JA, Johnell O, Oden A et al (2005) Smoking and fracture risk: a meta-analysis. Osteoporos Int 16:222–228PubMedCrossRef
17.
go back to reference Kanis JA, Oden A, Johnell O et al (2007) The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int 18:1033–1046PubMedCrossRef Kanis JA, Oden A, Johnell O et al (2007) The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int 18:1033–1046PubMedCrossRef
18.
go back to reference Black DM, Steinbuch M, Palermo L et al (2001) An assessment tool for predicting fracture risk in postmenopausal women. Osteoporos Int 12:519–528PubMedCrossRef Black DM, Steinbuch M, Palermo L et al (2001) An assessment tool for predicting fracture risk in postmenopausal women. Osteoporos Int 12:519–528PubMedCrossRef
19.
go back to reference Kanis JA, Gluer C-C, for the Committee of Scientific Advisors, International Osteoporosis Foundation (2000) An update on the diagnosis and assessment of osteoporosis with densitometry. Osteoporos Int 11:192–202PubMedCrossRef Kanis JA, Gluer C-C, for the Committee of Scientific Advisors, International Osteoporosis Foundation (2000) An update on the diagnosis and assessment of osteoporosis with densitometry. Osteoporos Int 11:192–202PubMedCrossRef
20.
21.
go back to reference Ramsay LE, Haq IU, Jackson PR, Yeo WW, Pickin DM, Payne JN (1996) Targeting lipid-lowering drug therapy for primary prevention of coronary artery disease: an updated Sheffield table. Lancet 348:387–388PubMedCrossRef Ramsay LE, Haq IU, Jackson PR, Yeo WW, Pickin DM, Payne JN (1996) Targeting lipid-lowering drug therapy for primary prevention of coronary artery disease: an updated Sheffield table. Lancet 348:387–388PubMedCrossRef
22.
go back to reference Ramsay LE, Haq IU, Jackson PR, Yeo WW (1996) The Sheffield table for primary prevention of coronary heart disease. Corrected. Lancet 348:1251–1252PubMedCrossRef Ramsay LE, Haq IU, Jackson PR, Yeo WW (1996) The Sheffield table for primary prevention of coronary heart disease. Corrected. Lancet 348:1251–1252PubMedCrossRef
23.
go back to reference Conroy RM, Pyörälä K, Fitzgerald AP et al (2003) Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Europ Heart J 11:987–1003CrossRef Conroy RM, Pyörälä K, Fitzgerald AP et al (2003) Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Europ Heart J 11:987–1003CrossRef
24.
go back to reference UKPDS Group (2001) The UKPDS Risk Engine: a model for the risk of coronary heart disease in type 2 diabetes (UKPDS 56). Clin Sci 101:671–679CrossRef UKPDS Group (2001) The UKPDS Risk Engine: a model for the risk of coronary heart disease in type 2 diabetes (UKPDS 56). Clin Sci 101:671–679CrossRef
25.
go back to reference UKPDS Group (2002) Risk of Stroke in Type 2 Diabetes Estimated by the UK Prospective Diabetes Study Risk Engine (UKPDS 60). Stroke 33:1776–1781CrossRef UKPDS Group (2002) Risk of Stroke in Type 2 Diabetes Estimated by the UK Prospective Diabetes Study Risk Engine (UKPDS 60). Stroke 33:1776–1781CrossRef
26.
go back to reference Breslow NE, Day NE (1987) Statistical methods in cancer research, vol 2. IARC Scientific Publications, no 32, Lyon 131–135 Breslow NE, Day NE (1987) Statistical methods in cancer research, vol 2. IARC Scientific Publications, no 32, Lyon 131–135
27.
go back to reference Oden A, Dawson A, Dere W, Johnell O, Jonsson B, Kanis JA (1988) Lifetime risk of hip fracture is underestimated. Osteoporos Int 8:599–603CrossRef Oden A, Dawson A, Dere W, Johnell O, Jonsson B, Kanis JA (1988) Lifetime risk of hip fracture is underestimated. Osteoporos Int 8:599–603CrossRef
28.
go back to reference Singer BR, McLauchlan GJ, Robinson CM, Christie J (1998) Epidemiology of fractures in 15,000 adults. The influence of age and gender. J Bone Joint Surg 80B:243–248CrossRef Singer BR, McLauchlan GJ, Robinson CM, Christie J (1998) Epidemiology of fractures in 15,000 adults. The influence of age and gender. J Bone Joint Surg 80B:243–248CrossRef
29.
go back to reference DeLusignan S, Valentin T, Chan T et al (2004) Problems with primary care data quality: Osteoporosis as an exemplar. Informatics in Primary Care 12:147–156 DeLusignan S, Valentin T, Chan T et al (2004) Problems with primary care data quality: Osteoporosis as an exemplar. Informatics in Primary Care 12:147–156
30.
go back to reference Kanis J, Brazier J, Stevenson M, Calvert W, Jones ML (2002) Treatment of established osteoporosis: a systematic review and cost-utility analysis. Health Technol Ass 6:1–146 Kanis J, Brazier J, Stevenson M, Calvert W, Jones ML (2002) Treatment of established osteoporosis: a systematic review and cost-utility analysis. Health Technol Ass 6:1–146
31.
go back to reference Kanis JA, Oden A, Johnell O, Jonsson B, de Laet C, Dawson A (2001) The burden of osteoporotic fractures: a method for setting intervention thresholds. Osteoporos Int 12:417–427PubMedCrossRef Kanis JA, Oden A, Johnell O, Jonsson B, de Laet C, Dawson A (2001) The burden of osteoporotic fractures: a method for setting intervention thresholds. Osteoporos Int 12:417–427PubMedCrossRef
32.
go back to reference Kanis JA, Johnell O, Oden A et al (2000) Long-term risk of osteoporotic fracture in Malmö. Osteoporos Int 11:669–674PubMedCrossRef Kanis JA, Johnell O, Oden A et al (2000) Long-term risk of osteoporotic fracture in Malmö. Osteoporos Int 11:669–674PubMedCrossRef
33.
go back to reference Tuppurainen M, Kroger H, Honkanen R et al (1995) Risks of perimenopausal fractures - a prospective population-based study. Acta Obstetr Gynecol Scand 74:624–628CrossRef Tuppurainen M, Kroger H, Honkanen R et al (1995) Risks of perimenopausal fractures - a prospective population-based study. Acta Obstetr Gynecol Scand 74:624–628CrossRef
34.
go back to reference Kanis JA, McCloskey EV, Powles T, Paterson AH, Ashley S, Spector T (1999) A high incidence of vertebral fracture in women with breast cancer. Br J Cancer 79:1179–1181PubMedCrossRef Kanis JA, McCloskey EV, Powles T, Paterson AH, Ashley S, Spector T (1999) A high incidence of vertebral fracture in women with breast cancer. Br J Cancer 79:1179–1181PubMedCrossRef
35.
go back to reference Melton LJ III, Khosla S, Malkasian GD, Achenbach SJ, Oberg AL, Riggs BL (2003) Fracture risk after bilateral oophorectomy in elderly women. J Bone Miner Res 18:900–905PubMedCrossRef Melton LJ III, Khosla S, Malkasian GD, Achenbach SJ, Oberg AL, Riggs BL (2003) Fracture risk after bilateral oophorectomy in elderly women. J Bone Miner Res 18:900–905PubMedCrossRef
36.
go back to reference Melton LJ III, Alothman KI, Khosla S, Achanbach SJ, Oberg AL, Zinake H (2003) Fracture risk following bilateral orchidectomy. J Urol 169:1747–1750PubMedCrossRef Melton LJ III, Alothman KI, Khosla S, Achanbach SJ, Oberg AL, Zinake H (2003) Fracture risk following bilateral orchidectomy. J Urol 169:1747–1750PubMedCrossRef
37.
go back to reference Stanley I II, Selmatt BP, Poses RM, Deiss WP (1991) Does hypogonadism contribute to the occurrence of a minimal trauma hip fracture in elderly men? J Amer Geriatric Soc 39:766–771 Stanley I II, Selmatt BP, Poses RM, Deiss WP (1991) Does hypogonadism contribute to the occurrence of a minimal trauma hip fracture in elderly men? J Amer Geriatric Soc 39:766–771
38.
go back to reference Wuster C, Abs R, Bengtsson BA, Benmarker H, Feld B, Rasmussen U et al (2001) The influence of growth hormone deficiency, growth hormone replacement therapy, and other aspects of hypopituitarism on fracture rate and bone mineral density. J Bone Miner Res 16:398–405PubMedCrossRef Wuster C, Abs R, Bengtsson BA, Benmarker H, Feld B, Rasmussen U et al (2001) The influence of growth hormone deficiency, growth hormone replacement therapy, and other aspects of hypopituitarism on fracture rate and bone mineral density. J Bone Miner Res 16:398–405PubMedCrossRef
39.
go back to reference Rigotti NA, Neer RM, Skates SJ, Herzog DB, Nussbaum SR (1991) The clinical course of osteoporosis in anorexia nervosa. A longitudinal study of cortical bone mass. JAMA 265:1133–1138PubMedCrossRef Rigotti NA, Neer RM, Skates SJ, Herzog DB, Nussbaum SR (1991) The clinical course of osteoporosis in anorexia nervosa. A longitudinal study of cortical bone mass. JAMA 265:1133–1138PubMedCrossRef
40.
go back to reference Gillberg C, Rastam M, Gillberg IC (1994) Anorexia nervosa: physical health and neurodevelopment at 16 and 21 years. Dev Med Child Neurol 36:567–575PubMedCrossRef Gillberg C, Rastam M, Gillberg IC (1994) Anorexia nervosa: physical health and neurodevelopment at 16 and 21 years. Dev Med Child Neurol 36:567–575PubMedCrossRef
41.
go back to reference Vestergaard P, Mosekilde L (2002) Fracture risk in patients with celiac disease, Crohn’s disease, and ulcerative colitis: a nationwide follow-up study of 16,416 patients in Denmark. Am J Epidemiol 156:1–10PubMedCrossRef Vestergaard P, Mosekilde L (2002) Fracture risk in patients with celiac disease, Crohn’s disease, and ulcerative colitis: a nationwide follow-up study of 16,416 patients in Denmark. Am J Epidemiol 156:1–10PubMedCrossRef
42.
go back to reference Bernstein CN, Blanchard JF, Leslie W, Wajda A, Yu BN (2000) The incidence of fracture among patients with inflammatory bowel disease: a population-based cohort study. Ann Intern Med 133:795–799PubMed Bernstein CN, Blanchard JF, Leslie W, Wajda A, Yu BN (2000) The incidence of fracture among patients with inflammatory bowel disease: a population-based cohort study. Ann Intern Med 133:795–799PubMed
43.
go back to reference Loftus EV, Crowson C, Sandborn WJ, Tremaine WJ, O’Fallon WM, Melton LJ III (2000) Long-term fracture risk in patients with Crohn’s disease: a population-based study in Olmsted County, Minnesota. Gastroenterol 123:468–475CrossRef Loftus EV, Crowson C, Sandborn WJ, Tremaine WJ, O’Fallon WM, Melton LJ III (2000) Long-term fracture risk in patients with Crohn’s disease: a population-based study in Olmsted County, Minnesota. Gastroenterol 123:468–475CrossRef
44.
go back to reference Van Staa T-P, Cooper C, Brusst LS, Leufkens H, Javaid MK, Arden NK (2003) Inflammatory bowel disease and the risk of fracture. Gastroenterol 125:1591–1597CrossRef Van Staa T-P, Cooper C, Brusst LS, Leufkens H, Javaid MK, Arden NK (2003) Inflammatory bowel disease and the risk of fracture. Gastroenterol 125:1591–1597CrossRef
45.
go back to reference Vestergaard P, Krogh K, Rejnmark L, Mosekilde L (1998) Fracture rates and risk factors for fractures in patients with spinal cord injury. Spinal Cord 36:790–796PubMedCrossRef Vestergaard P, Krogh K, Rejnmark L, Mosekilde L (1998) Fracture rates and risk factors for fractures in patients with spinal cord injury. Spinal Cord 36:790–796PubMedCrossRef
46.
go back to reference Vestergaard P, Glerup IT, Steffensen BF, Rejnmark I, Rabbek J, Mosekilde I (2001) Fracture risk in patients with muscular dystrophy and spinal muscular atrophy. J Rehabilitation Med 33:150–155CrossRef Vestergaard P, Glerup IT, Steffensen BF, Rejnmark I, Rabbek J, Mosekilde I (2001) Fracture risk in patients with muscular dystrophy and spinal muscular atrophy. J Rehabilitation Med 33:150–155CrossRef
47.
go back to reference Johnell O, Melton LJ III, Atkinson EJ, O’Fallon WM, Kurland LT (1992) Fracture risk in patients with Parkinsonism: a population-based study in Olmsted County, Minnesota. Age Ageing 21:32–38PubMedCrossRef Johnell O, Melton LJ III, Atkinson EJ, O’Fallon WM, Kurland LT (1992) Fracture risk in patients with Parkinsonism: a population-based study in Olmsted County, Minnesota. Age Ageing 21:32–38PubMedCrossRef
48.
go back to reference Dennis MS, Lo KM, McDowall M, West T (2002) Fractures after stroke: frequency, types and associations. Stroke 33:728–734PubMedCrossRef Dennis MS, Lo KM, McDowall M, West T (2002) Fractures after stroke: frequency, types and associations. Stroke 33:728–734PubMedCrossRef
49.
go back to reference Kanis JA, Oden A, Johnell O (2001) Acute and long-term increase in fracture risk after hospitalisation for stroke. Stroke 32:702–706PubMed Kanis JA, Oden A, Johnell O (2001) Acute and long-term increase in fracture risk after hospitalisation for stroke. Stroke 32:702–706PubMed
50.
go back to reference Donnelly S, Doyle DV, Denton A, Roffe I, McCloskey EV, Spector TD (1994) Bone mineral density and vertebral compression fracture rates in ankylosing spondylitis. Ann Rheum Dis 53:117–121PubMed Donnelly S, Doyle DV, Denton A, Roffe I, McCloskey EV, Spector TD (1994) Bone mineral density and vertebral compression fracture rates in ankylosing spondylitis. Ann Rheum Dis 53:117–121PubMed
51.
go back to reference Royal College of Physicians (2002) Glucocorticoid-induced osteoporosis. Guidelines on prevention and treatment. Bone and Tooth Society of Great Britain, National Osteoporosis Society and Royal College of Physicians. Royal College of Physicians London UK Royal College of Physicians (2002) Glucocorticoid-induced osteoporosis. Guidelines on prevention and treatment. Bone and Tooth Society of Great Britain, National Osteoporosis Society and Royal College of Physicians. Royal College of Physicians London UK
52.
go back to reference Ramsey-Goldman R, Dunn JE, Dunlop DD (1999) Increased risk of fracture in patients receiving solid organ transplants. J Bone Miner Res 14:456–463PubMedCrossRef Ramsey-Goldman R, Dunn JE, Dunlop DD (1999) Increased risk of fracture in patients receiving solid organ transplants. J Bone Miner Res 14:456–463PubMedCrossRef
53.
go back to reference Vantour LM, Melton LJ 3rd, Clarke I, Achenbach SJ, Oberg AL, McCarthy JT (2004) Long-term fracture risk following renal transplantation: a population-based study. Osteoporos Int 15:160–167CrossRef Vantour LM, Melton LJ 3rd, Clarke I, Achenbach SJ, Oberg AL, McCarthy JT (2004) Long-term fracture risk following renal transplantation: a population-based study. Osteoporos Int 15:160–167CrossRef
54.
go back to reference Shane E, Papadoupoulos A, Staron RB et al (1999) Bone loss and fracture after lung transplantation. Transplantation 68:220–227PubMedCrossRef Shane E, Papadoupoulos A, Staron RB et al (1999) Bone loss and fracture after lung transplantation. Transplantation 68:220–227PubMedCrossRef
55.
go back to reference Nicodemus KK, Folsom AR, Iowa Women’s Health Study (2001) Type 1 and type 2 diabetes and incident hip fractures in postmenopausal women. Diabetes Care 24:1192–1197PubMedCrossRef Nicodemus KK, Folsom AR, Iowa Women’s Health Study (2001) Type 1 and type 2 diabetes and incident hip fractures in postmenopausal women. Diabetes Care 24:1192–1197PubMedCrossRef
56.
go back to reference U.S. Department of Health and Human Services (2004) Bone health and osteoporosis: a report of the Surgeon General. Rockville, MD, U.S. Department of Health and Human Services, Office of the Surgeon General U.S. Department of Health and Human Services (2004) Bone health and osteoporosis: a report of the Surgeon General. Rockville, MD, U.S. Department of Health and Human Services, Office of the Surgeon General
57.
go back to reference Vestergaard P, Rejnmark L, Mosekilde L (2005) Relative fracture risk in patients with diabetes mellitus, and the impact of insulin and oral antidiabetic medication on relative fracture risk. Diabetologia 48:1292–1299PubMedCrossRef Vestergaard P, Rejnmark L, Mosekilde L (2005) Relative fracture risk in patients with diabetes mellitus, and the impact of insulin and oral antidiabetic medication on relative fracture risk. Diabetologia 48:1292–1299PubMedCrossRef
58.
go back to reference Schwartz AV, Sellmeyer DE, Ensrud KE et al (2001) Older women with diabetes have an increased risk of fracture: a prospective study. J Clin Endocrinol Metab 86:32–38PubMedCrossRef Schwartz AV, Sellmeyer DE, Ensrud KE et al (2001) Older women with diabetes have an increased risk of fracture: a prospective study. J Clin Endocrinol Metab 86:32–38PubMedCrossRef
59.
go back to reference Vestergaard P, Mosekilde L (2003) Hyperthyroidism, bone mineral, and fracture risk - a meta-analysis. Thyroid 13:585–593PubMedCrossRef Vestergaard P, Mosekilde L (2003) Hyperthyroidism, bone mineral, and fracture risk - a meta-analysis. Thyroid 13:585–593PubMedCrossRef
60.
go back to reference Vestergaard P, Rejnmark L, Weeke J, Mosekilde L (2000) Fracture risk in patients treated with hyperthyroidism. Thyroid 10:341–348PubMed Vestergaard P, Rejnmark L, Weeke J, Mosekilde L (2000) Fracture risk in patients treated with hyperthyroidism. Thyroid 10:341–348PubMed
61.
go back to reference Vestergaard P, Mosekilde L (2002) Fractures in patients with hyperthyroidism and hypothyroidism: a nationwide follow-up study in 16,249 patients. Thyroid 12:411–419PubMedCrossRef Vestergaard P, Mosekilde L (2002) Fractures in patients with hyperthyroidism and hypothyroidism: a nationwide follow-up study in 16,249 patients. Thyroid 12:411–419PubMedCrossRef
62.
go back to reference Melton LJ 3rd, Ardila E, Crowson CS, O’Fallon WM, Khosla S (2000) Fractures following thyroidectomy in women: a population-based cohort study. Bone 27:695–700PubMedCrossRef Melton LJ 3rd, Ardila E, Crowson CS, O’Fallon WM, Khosla S (2000) Fractures following thyroidectomy in women: a population-based cohort study. Bone 27:695–700PubMedCrossRef
63.
go back to reference Bauer DC, Ettinger B, Nevitt MC, Stone KL, Study of Osteoporotic Fractures Research Group (2001) Risk for fracture in women with low serum levels of thyroid-stimulating hormone. Ann Intern Med 134:561–568PubMed Bauer DC, Ettinger B, Nevitt MC, Stone KL, Study of Osteoporotic Fractures Research Group (2001) Risk for fracture in women with low serum levels of thyroid-stimulating hormone. Ann Intern Med 134:561–568PubMed
64.
go back to reference Looker AC, Wahner HW, Dunn WL, Calvo MS, Harris TB, Heyse SP (1998) Updated data on proximal femur bone mineral levels of US adults. Osteoporos Int 8:468–486PubMedCrossRef Looker AC, Wahner HW, Dunn WL, Calvo MS, Harris TB, Heyse SP (1998) Updated data on proximal femur bone mineral levels of US adults. Osteoporos Int 8:468–486PubMedCrossRef
65.
go back to reference Burger H, de Laet CE, Weel AE, Hofman A, Pols HA (1999) Added value of bone mineral density in hip fracture risk scores. Bone 25:369–374PubMedCrossRef Burger H, de Laet CE, Weel AE, Hofman A, Pols HA (1999) Added value of bone mineral density in hip fracture risk scores. Bone 25:369–374PubMedCrossRef
66.
go back to reference Albrand G, Munoz F, Sornay RE, Duboeuf F, Delmas PD (2001) Independent predictors of all osteoporosis-related fractures in healthy postmenopausal women: The OFELY Study. Bone 32:78–85CrossRef Albrand G, Munoz F, Sornay RE, Duboeuf F, Delmas PD (2001) Independent predictors of all osteoporosis-related fractures in healthy postmenopausal women: The OFELY Study. Bone 32:78–85CrossRef
67.
go back to reference Carroll J, Testa M, Erat K, LeBoff M, Fuleihan G-EH (1997) Modelling fracture risk using bone density, age, and years since menopause. Am J of Preventive Med 13:447–452 Carroll J, Testa M, Erat K, LeBoff M, Fuleihan G-EH (1997) Modelling fracture risk using bone density, age, and years since menopause. Am J of Preventive Med 13:447–452
68.
go back to reference Dargent-Molina P, Douchin MN, Cormier C, Meunier PJ, Bréart G (2002) Use of clinical risk factors in elderly women with low bone mineral density to identify women at higher risk of hip fracture: The EPIDOS prospective study. Osteoporos Int 13:593–599PubMedCrossRef Dargent-Molina P, Douchin MN, Cormier C, Meunier PJ, Bréart G (2002) Use of clinical risk factors in elderly women with low bone mineral density to identify women at higher risk of hip fracture: The EPIDOS prospective study. Osteoporos Int 13:593–599PubMedCrossRef
69.
go back to reference Girman CJ, Chandler JM, Zimmerman S et al (2002) Prediction of fracture in nursing home residents. J Am Geriatr Soc 50:1341–1347PubMedCrossRef Girman CJ, Chandler JM, Zimmerman S et al (2002) Prediction of fracture in nursing home residents. J Am Geriatr Soc 50:1341–1347PubMedCrossRef
70.
go back to reference Honkanen RJ, Honkanen K, Kroger H, Alhava E, Tuppurainen M, Saarikoski S (2000) Risk factors for perimenopausal distal forearm fracture.Osteoporos Int 11:265–270CrossRef Honkanen RJ, Honkanen K, Kroger H, Alhava E, Tuppurainen M, Saarikoski S (2000) Risk factors for perimenopausal distal forearm fracture.Osteoporos Int 11:265–270CrossRef
71.
go back to reference Leslie WD, Metge C, Salamon EA, Yuen CK (2002) Bone mineral density testing in healthy postmenopausal women. The role of clinical risk factor assessment in determining fracture risk. J Clin Densitom 5:117–130PubMedCrossRef Leslie WD, Metge C, Salamon EA, Yuen CK (2002) Bone mineral density testing in healthy postmenopausal women. The role of clinical risk factor assessment in determining fracture risk. J Clin Densitom 5:117–130PubMedCrossRef
72.
go back to reference Miller PD, Barlas S, Brenneman SK et al (2004) An approach to identifying osteopenic women at increased short-term risk of fracture. Arch Int Med 164:1113–1120CrossRef Miller PD, Barlas S, Brenneman SK et al (2004) An approach to identifying osteopenic women at increased short-term risk of fracture. Arch Int Med 164:1113–1120CrossRef
73.
go back to reference Westfall G, Littlefield R, Heaton A, Martin S (2001) Methodology for identifying patients at high risk for osteoporotic fracture. Clin Therap 23:1570–1588CrossRef Westfall G, Littlefield R, Heaton A, Martin S (2001) Methodology for identifying patients at high risk for osteoporotic fracture. Clin Therap 23:1570–1588CrossRef
74.
go back to reference Colón-Emeric CS, Pieper CF, Artz MB (2002) Can historical and functional risk factors be used to predict fractures in community-dwelling older adults? Development and validation of a clinical tool. Osteoporos Int 13:955–961PubMedCrossRef Colón-Emeric CS, Pieper CF, Artz MB (2002) Can historical and functional risk factors be used to predict fractures in community-dwelling older adults? Development and validation of a clinical tool. Osteoporos Int 13:955–961PubMedCrossRef
75.
go back to reference van Staa TP, Leufkens H-GM, Cooper C (2002) Utility of medical and drug history in fracture risk prediction among men and women. Bone 31:508–514PubMedCrossRef van Staa TP, Leufkens H-GM, Cooper C (2002) Utility of medical and drug history in fracture risk prediction among men and women. Bone 31:508–514PubMedCrossRef
76.
go back to reference Van Staa T-P, Geusens P, Pols HAP, De Laet C, Leufkens HCM, Cooper C (2005) A simple score for estimating the long-term risk of fracture in patients using oral glucocorticoids. Quart Jl Med 98:191–198 Van Staa T-P, Geusens P, Pols HAP, De Laet C, Leufkens HCM, Cooper C (2005) A simple score for estimating the long-term risk of fracture in patients using oral glucocorticoids. Quart Jl Med 98:191–198
77.
go back to reference McGrother CW, Donaldson M-MK, Clayton D, Abrams KR, Clarke M (2002) Evaluation of a hip fracture risk score for assessing elderly women: the Melton Osteoporotic Fracture (MOF) study. Osteoporos Int 13:89–96PubMedCrossRef McGrother CW, Donaldson M-MK, Clayton D, Abrams KR, Clarke M (2002) Evaluation of a hip fracture risk score for assessing elderly women: the Melton Osteoporotic Fracture (MOF) study. Osteoporos Int 13:89–96PubMedCrossRef
78.
go back to reference Walter LC, Lui LY, Eng C, Covinsky KE (2003) Risk of hip fracture in disabled community-living older adults. J Am Geriatr Soc 51:50–55PubMedCrossRef Walter LC, Lui LY, Eng C, Covinsky KE (2003) Risk of hip fracture in disabled community-living older adults. J Am Geriatr Soc 51:50–55PubMedCrossRef
79.
go back to reference Food and Drug Administration (1994) Guidelines for preclinical and clinical evaluation of agents used in the prevention or treatment of postmenopausal osteoporosis. Division of Metabolism and Endocrine Drug Products, Rockville, MD Food and Drug Administration (1994) Guidelines for preclinical and clinical evaluation of agents used in the prevention or treatment of postmenopausal osteoporosis. Division of Metabolism and Endocrine Drug Products, Rockville, MD
80.
go back to reference Committee for Medicinal Products for Human Use (CHMP) (2006) Guideline on the evaluation of medicinal products in the treatment of primary osteoporosis. Ref CPMP/EWP/552/95Rev.2. London, CHMP, Nov Committee for Medicinal Products for Human Use (CHMP) (2006) Guideline on the evaluation of medicinal products in the treatment of primary osteoporosis. Ref CPMP/EWP/552/95Rev.2. London, CHMP, Nov
81.
go back to reference Saag KG, Emkey R, Schnitzer TJ et al (1998) Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-induced Osteoporosis Intervention Study Group. N Engl J Med 339:292–299PubMedCrossRef Saag KG, Emkey R, Schnitzer TJ et al (1998) Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-induced Osteoporosis Intervention Study Group. N Engl J Med 339:292–299PubMedCrossRef
82.
go back to reference Adachi JD, Saag KG, Delmas PD et al (2001) Two year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: a randomised, double-blind, placebo-controlled extension trial. Arthr Rheum 44:202–211CrossRef Adachi JD, Saag KG, Delmas PD et al (2001) Two year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: a randomised, double-blind, placebo-controlled extension trial. Arthr Rheum 44:202–211CrossRef
83.
go back to reference Reginster JY, Minne HW, Sorensen OH et al (2000) Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral efficacy with risedronate therapy (VERT) study group. Osteoporos Int 11:83–91PubMedCrossRef Reginster JY, Minne HW, Sorensen OH et al (2000) Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral efficacy with risedronate therapy (VERT) study group. Osteoporos Int 11:83–91PubMedCrossRef
84.
go back to reference Kanis JA, Barton I, Johnell O (2005) Risedronate decreases fracture risk in patients selected solely on the basis of prior vertebral fracture. Osteoporos Int 16:475–482PubMedCrossRef Kanis JA, Barton I, Johnell O (2005) Risedronate decreases fracture risk in patients selected solely on the basis of prior vertebral fracture. Osteoporos Int 16:475–482PubMedCrossRef
85.
go back to reference McCloskey EV, Selby P, Davies M et al (2004) Clodronate reduces vertebral fracture risk in women with post-menopausal or secondary osteoporosis: results of a double blind placebo-controlled 3 year study. J Bone Miner Res 19:728–736PubMedCrossRef McCloskey EV, Selby P, Davies M et al (2004) Clodronate reduces vertebral fracture risk in women with post-menopausal or secondary osteoporosis: results of a double blind placebo-controlled 3 year study. J Bone Miner Res 19:728–736PubMedCrossRef
86.
go back to reference Roux C, Reginster JY, Fechtenbaum J et al (2006) Vertebral fracture risk reduction with strontium ranelate in women with post-menopausal osteoporosis is independent of baseline risk factors. J Bone Miner Res 21:536–542PubMedCrossRef Roux C, Reginster JY, Fechtenbaum J et al (2006) Vertebral fracture risk reduction with strontium ranelate in women with post-menopausal osteoporosis is independent of baseline risk factors. J Bone Miner Res 21:536–542PubMedCrossRef
87.
go back to reference Marcus R, Wang O, Satterwhite J et al (2003) The skeletal response to teriparatide is largely independent of age, initial bone mineral density and prevalent vertebral fractures in postmenopausal women with osteoporosis. J Bone Miner Res 18:18–23PubMedCrossRef Marcus R, Wang O, Satterwhite J et al (2003) The skeletal response to teriparatide is largely independent of age, initial bone mineral density and prevalent vertebral fractures in postmenopausal women with osteoporosis. J Bone Miner Res 18:18–23PubMedCrossRef
88.
go back to reference Johnell O, Kanis JA, Black DM et al (2004) Association between baseline risk factors and vertebral fracture risk in the Multiple Outcomes of Raloxifene Evaluation (MORE) study. J Bone Miner Res 19:764–772PubMedCrossRef Johnell O, Kanis JA, Black DM et al (2004) Association between baseline risk factors and vertebral fracture risk in the Multiple Outcomes of Raloxifene Evaluation (MORE) study. J Bone Miner Res 19:764–772PubMedCrossRef
89.
go back to reference McClung MR, Geusens P, Miller PD et al (2001) Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group. New Engl J Med 344:333–340PubMedCrossRef McClung MR, Geusens P, Miller PD et al (2001) Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group. New Engl J Med 344:333–340PubMedCrossRef
90.
go back to reference Cummings SR, Black DM, Thompson D et al (1998) Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial. JAMA 280:2077–2082PubMedCrossRef Cummings SR, Black DM, Thompson D et al (1998) Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial. JAMA 280:2077–2082PubMedCrossRef
91.
go back to reference Davison KS, Siminoski K, Chik C, Jen H, Warshawski R, Lee K (2003) Impact of height loss due to vertebral fractures on body mass index. J Bone Miner Res 18(Suppl 2):S243 Davison KS, Siminoski K, Chik C, Jen H, Warshawski R, Lee K (2003) Impact of height loss due to vertebral fractures on body mass index. J Bone Miner Res 18(Suppl 2):S243
92.
go back to reference Midanik LT (1988) Validity of self-reported alcohol use: a literature review and assessment. Br J Addict 83:1019–1030PubMedCrossRef Midanik LT (1988) Validity of self-reported alcohol use: a literature review and assessment. Br J Addict 83:1019–1030PubMedCrossRef
93.
go back to reference Standing Medical Advisory Committee to the Secretaries of State for Health and for Wales (1989) Drinking problems. A challenge for every doctor. HMSO, London Standing Medical Advisory Committee to the Secretaries of State for Health and for Wales (1989) Drinking problems. A challenge for every doctor. HMSO, London
94.
go back to reference Van Staa TP, Leufkens HGM, Abenhaim L, Zhang B, Cooper C (2000) Fracture and oral corticosteroids: relationship to daily and cumulative dose. Rheumatol 39:1383–1389CrossRef Van Staa TP, Leufkens HGM, Abenhaim L, Zhang B, Cooper C (2000) Fracture and oral corticosteroids: relationship to daily and cumulative dose. Rheumatol 39:1383–1389CrossRef
95.
go back to reference Delmas PD, Genant HK, Crans GG et al (2003) Severity of prevalent vertebral fractures and the risk of subsequent vertebral and nonvertebral fractures: results from the MORE trial. Bone 33:522–532PubMedCrossRef Delmas PD, Genant HK, Crans GG et al (2003) Severity of prevalent vertebral fractures and the risk of subsequent vertebral and nonvertebral fractures: results from the MORE trial. Bone 33:522–532PubMedCrossRef
96.
go back to reference Kanis JA, Adams J, Borgström B et al (2008) The cost-effectiveness of alendronate in the management of osteoporosis. Bone, (in press) Kanis JA, Adams J, Borgström B et al (2008) The cost-effectiveness of alendronate in the management of osteoporosis. Bone, (in press)
97.
go back to reference Kanis JA, Johnell O, De Laet C, Jonsson B, Oden A, Oglesby A (2002) International variations in hip fracture probabilities: implications for risk assessment. J Bone Miner Res 17:1237–1244PubMedCrossRef Kanis JA, Johnell O, De Laet C, Jonsson B, Oden A, Oglesby A (2002) International variations in hip fracture probabilities: implications for risk assessment. J Bone Miner Res 17:1237–1244PubMedCrossRef
98.
go back to reference World Health Organization (2008) Assessment of osteoporosis at the primary health care level. WHO, Geneva (in press) World Health Organization (2008) Assessment of osteoporosis at the primary health care level. WHO, Geneva (in press)
99.
go back to reference Kanis JA, on behalf of the World Health Organization Scientific Group (2008) Assessment of osteoporosis at the primary health-care level. Technical Report. WHO Collaborating Centre, University of Sheffield, UK (in press) Kanis JA, on behalf of the World Health Organization Scientific Group (2008) Assessment of osteoporosis at the primary health-care level. Technical Report. WHO Collaborating Centre, University of Sheffield, UK (in press)
Metadata
Title
FRAX™ and the assessment of fracture probability in men and women from the UK
Authors
J. A. Kanis
O. Johnell
A. Oden
H. Johansson
E. McCloskey
Publication date
01-04-2008
Publisher
Springer-Verlag
Published in
Osteoporosis International / Issue 4/2008
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-007-0543-5

Other articles of this Issue 4/2008

Osteoporosis International 4/2008 Go to the issue